Source · Select Committees · Home Affairs Committee
Recommendation 47
47
Paragraph: 169
Long-acting buprenorphine shows encouraging results for opioid treatment in Wales.
Conclusion
We welcome the 10-Year Drug Strategy’s recognition of the potential positive impact of long-acting buprenorphine. We think that the use of Buvidal in Wales has provided a very encouraging UK evidence base and proved that it is an effective form of opioid substitution treatment.
Paragraph Reference:
169
Government Response
A response document is linked to this report, dated 14 November 2023. Response attribution to this conclusion has not been verified. Read the response document ↗